Preoperative neoadjuvant chemoradiotherapy provides borderline resectable thoracic esophageal cancer with equivalent treatment results as clinically T3 thoracic esophageal cancer.
Akiyuki WakitaSatoru MotoyamaYusuke SatoYushi NagakiHiromu FujitaKohei KemuriyamaKenjiro HayashiKazuhiro ImaiHiroshi NanjoYoshihiro MinamiyaPublished in: Annals of gastroenterological surgery (2023)
Preoperative neoadjuvant chemoradiotherapy appears to be a promising treatment for patients with borderline resectable thoracic esophageal squamous cell carcinoma.